Literature DB >> 27496712

PAK4 Phosphorylates p53 at Serine 215 to Promote Liver Cancer Metastasis.

Hai-Tao Xu1, Wai-Lung Lai1, Heong-Fai Liu1, Leo Lap-Yan Wong1, Irene Oi-Lin Ng2, Yick Pang Ching3.   

Abstract

PAK4 kinase contributes to signaling pathways controlling cancer cell transformation, invasion, and survival, but its clinicopathological impact has begun to emerge only recently. Here we report that PAK4 overexpression in hepatocellular carcinoma (HCC) conveys aggressive metastatic properties. A novel nuclear splice isoform of PAK4 lacking exon 2 sequences was isolated as part of our studies. By stably overexpressing or silencing PAK4 in HCC cells, we showed that it was critical for their migration. Mechanistic investigations in this setting revealed that PAK4 directly phosphorylated p53 at S215, which not only attenuated transcriptional transactivation activity but also inhibited p53-mediated suppression of HCC cell invasion. Taken together, our results showed how PAK4 overexpression in HCC promotes metastatic invasion by regulating p53 phosphorylation. Cancer Res; 76(19); 5732-42. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27496712     DOI: 10.1158/0008-5472.CAN-15-3373

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Recognition of physiological phosphorylation sites by p21-activated kinase 4.

Authors:  Ashwin K Chetty; Joel A Sexton; Byung Hak Ha; Benjamin E Turk; Titus J Boggon
Journal:  J Struct Biol       Date:  2020-06-23       Impact factor: 2.867

Review 2.  The significance of PAK4 in signaling and clinicopathology: A review.

Authors:  Xinbo Yu; Changwei Huang; Jiyuan Liu; Xinyu Shi; Xiaodong Li
Journal:  Open Life Sci       Date:  2022-06-20       Impact factor: 1.311

3.  Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression.

Authors:  Darshan S Chandrashekar; Balabhadrapatruni V S K Chakravarthi; Alyncia D Robinson; Joshua C Anderson; Sumit Agarwal; Sai Akshaya Hodigere Balasubramanya; Marie-Lisa Eich; Akhilesh Kumar Bajpai; Sravanthi Davuluri; Maya S Guru; Arjun S Guru; Gurudatta Naik; Deborah L Della Manna; Kshitish K Acharya; Shannon Carskadon; Upender Manne; David K Crossman; James E Ferguson; William E Grizzle; Nallasivam Palanisamy; Christopher D Willey; Michael R Crowley; George J Netto; Eddy S Yang; Sooryanarayana Varambally; Guru Sonpavde
Journal:  Oncogene       Date:  2020-03-30       Impact factor: 9.867

4.  Understanding p53 functions through p53 antibodies.

Authors:  Kanaga Sabapathy; David P Lane
Journal:  J Mol Cell Biol       Date:  2019-04-01       Impact factor: 6.216

5.  p53 modifications: exquisite decorations of the powerful guardian.

Authors:  Yanqing Liu; Omid Tavana; Wei Gu
Journal:  J Mol Cell Biol       Date:  2019-07-19       Impact factor: 6.216

6.  PAK4 phosphorylating RUNX1 promotes ERα-positive breast cancer-induced osteolytic bone destruction.

Authors:  Lina Tang; Yunling Gao; Yongqi Song; Yang Li; Yanshu Li; Hongyan Zhang; Danni Li; Jiabin Li; Caigang Liu; Feng Li
Journal:  Int J Biol Sci       Date:  2020-05-25       Impact factor: 6.580

Review 7.  Deciphering the PTM codes of the tumor suppressor p53.

Authors:  Jia Wen; Donglai Wang
Journal:  J Mol Cell Biol       Date:  2022-01-21       Impact factor: 6.216

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.